Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for NNVC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
March 31, 2026 10.22M
December 31, 2025 12.27M
September 30, 2025 8.357M
June 30, 2025 8.824M
March 31, 2025 10.03M
December 31, 2024 11.57M
September 30, 2024 11.74M
June 30, 2024 12.82M
March 31, 2024 11.46M
December 31, 2023 13.40M
September 30, 2023 15.42M
June 30, 2023 16.90M
March 31, 2023 18.58M
December 31, 2022 20.34M
September 30, 2022 22.08M
June 30, 2022 23.49M
March 31, 2022 25.14M
December 31, 2021 26.81M
September 30, 2021 29.18M
June 30, 2021 30.26M
March 31, 2021 32.76M
December 31, 2020 28.09M
September 30, 2020 31.85M
June 30, 2020 23.91M
March 31, 2020 16.53M
Date Value
December 31, 2019 11.62M
September 30, 2019 11.79M
June 30, 2019 13.45M
March 31, 2019 15.39M
December 31, 2018 15.00M
September 30, 2018 17.37M
June 30, 2018 18.55M
March 31, 2018 22.34M
December 31, 2017 23.73M
September 30, 2017 25.27M
June 30, 2017 27.00M
March 31, 2017 28.58M
December 31, 2016 31.36M
September 30, 2016 34.22M
June 30, 2016 36.63M
March 31, 2016 38.32M
December 31, 2015 40.85M
September 30, 2015 42.30M
June 30, 2015 44.19M
March 31, 2015 45.60M
December 31, 2014 47.60M
September 30, 2014 49.02M
June 30, 2014 44.57M
March 31, 2014 40.95M
December 31, 2013 22.89M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. 1.743B
Alnylam Pharmaceuticals, Inc. 5.559B
Anika Therapeutics, Inc. 183.47M
Savara, Inc. 192.14M
Vericel Corp. 502.87M

Total Assets (Quarterly) Related Metrics